Population
Murine model of cardiac allograft vasculopathy
Design
Preclinical
Follow-up
1 to 2 months
Authors
Loading...
Supports local immune mediation in cardiac allograft vasculopathy models; leaves open translation to human transplant vasculopathy.
Experimental cardiac allograft vasculopathy is a local immune-mediated process where endothelial and medial smooth muscle cells express VCAM-1 and unmatched MHC antigens, acting as immune targets and stimulators.
Ardehali et al. (1995) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: